Aspirin or Clopidogrel

ApprovedSmall molecule

Aspirin or Clopidogrel is one of 132 small molecule programs targeting Cardiovascular Disease. It is currently in Approved.

Indications

Total Trials

Active Trials

131

Competitors

Pipeline

Status by Indication[3][1]

Indication

Cardiovascular DiseaseActive, not recruiting

StrokeActive, not recruiting

AneurysmActive, not recruiting

Kawasaki DiseaseRecruiting

Ischemic StrokeActive, not recruiting

Cardiovascular DiseaseApproved

Active, not recruiting

StrokePhase 3

Active, not recruiting

AneurysmApproved

Active, not recruiting

Kawasaki DiseaseApproved

Recruiting

Ischemic StrokePreclinical

Active, not recruiting

Competition

Competitive Landscape

461 competitors in Stroke

#DrugCompanyPhaseTrials

Aspirin or Clopidogrel

SSunnybrook Health Sciences Centre

Approved

1 2

Zometa

Pfizer

Preclinical

1 3

Folvite

Eli Lilly

Preclinical

1 4

Proamatine

Pradaxa

3 6

Periactin

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

1 7

Haldol

DDePuy Orthopaedics

Preclinical

1 8

Inderal

Mylan Pharmaceuticals Inc

Botulinum Toxin a

1 10

Antidepressant

Johnson & Johnson

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2027

ApprovedRecruiting

Kawasaki Disease

NCT05643651

Q4 2031

Phase 3Not yet recruiting

Stroke

NCT07454707

Clinical

Trials by Indication[1]

Stroke1 trial

Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial

Not yet recruiting·SSunnybrook Health Sciences Centre·Phase 3·NCT07454707·1,204 enrolled

Ischemic stroke1 trial

Blood Pressure Variability and the Prognosis of Ischemic Stroke With Intracranial Artery Stenosis

Unknown status·RRenJi Hospital·N/A·NCT01665235·200 enrolled

Cardiovascular Disease1 trial

Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.

Unknown status·HHospital Arnau de Vilanova·Phase 4·NCT00734123·2,948 enrolled

Kawasaki Disease1 trial

Rivaroxaban Versus Warfarin for Thromboprophylaxis in Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease: a Multicenter, Open-label, Parallel, Exploratory, Randomized Controlled Trial

Recruiting·CChildren's Hospital of Fudan University·Approved·NCT05643651·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Aspirin or Clopidogrel. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Aspirin or Clopidogrel compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Aspirin or Clopidogrel. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sunnybrook Health Sciences Centre company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: SSunnybrook Health Sciences Centre

Aspirin or Clopidogrel

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2027

Q4 2031

Trials by Indication[1]

Stroke1 trial

Ischemic stroke1 trial

Cardiovascular Disease1 trial

Kawasaki Disease1 trial

References

Drug Info

Quick Facts

Related News